CD82 and breast carcinoma: In an attempt to investigate the mechanism underlying the downregulation of KAI1 in breast cancer, a process that precedes metastasis, a group of investigators from Saudi Arabia studied the expression of KAI1 in 90 formalin-fixed breast cancer tissue obtained from Saudi patients (Kussaibi et al., 2019).